Abstract

Cancer research has seen explosive development exploring deep learning (DL) techniques for analysing magnetic resonance imaging (MRI) images for predicting brain tumours. We have observed a substantial gap in explanation, interpretability, and high accuracy for DL models. Consequently, we propose an explanation-driven DL model by utilising a convolutional neural network (CNN), local interpretable model-agnostic explanation (LIME), and Shapley additive explanation (SHAP) for the prediction of discrete subtypes of brain tumours (meningioma, glioma, and pituitary) using an MRI image dataset. Unlike previous models, our model used a dual-input CNN approach to prevail over the classification challenge with images of inferior quality in terms of noise and metal artifacts by adding Gaussian noise. Our CNN training results reveal 94.64% accuracy as compared to other state-of-the-art methods. We used SHAP to ensure consistency and local accuracy for interpretation as Shapley values examine all future predictions applying all possible combinations of inputs. In contrast, LIME constructs sparse linear models around each prediction to illustrate how the model operates in the immediate area. Our emphasis for this study is interpretability and high accuracy, which is critical for realising disparities in predictive performance, helpful in developing trust, and essential in integration into clinical practice. The proposed method has a vast clinical application that could potentially be used for mass screening in resource-constraint countries.

Highlights

  • According to the world health organization (WHO) world cancer report (2020), cancer is amongst the leading death-causing diseases, ranked second, accounting for nearly 10 million deaths in 2020 (Sung et al, 2021)

  • We have achieved high accuracy of (94.64%) brain magnetic resonance imaging (MRI) images compared to other state-of-the-art models

  • The model was iterated for 20 epochs, and during callback in convolutional neural network (CNN) modules, we had monitored the loss with min mode and patience level of three to cross the over-fitting

Read more

Summary

Introduction

According to the world health organization (WHO) world cancer report (2020), cancer is amongst the leading death-causing diseases, ranked second (after cardiovascular disease), accounting for nearly 10 million deaths in 2020 (Sung et al, 2021). Cancer screening is a different and more complicated public health approach that needs extra resources, infrastructure, and coordination. The WHO recommends the implementation of screening programs when the following conditions are fulfilled (Sung et al, 2021): 1. 3. The prevalence of the disease is extreme enough to justify the screening. The total prevalence of all central nervous system tumours is 3.9 per 100,000 persons worldwide; the incidence differs with age, gender, race, and region and is extremely frequent in Northern Europe, followed by Australia, the United States, and Canada. Meningioma is the most common one, accounting for 36.8% of all tumours; glioma is the most widespread malignant tumour, accounting for 75% of central nervous system malignant tumours, with a total incidence of six cases per 100,000 people per year. The interpretation of MRI is predominantly centred on the opinions of radiologists

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.